Clonal Myeloproliferative Disorders in Patients with Down Syndrome—Treatment and Outcome Results from an Institution in Argentina

Clonal Myeloproliferative Disorders in Patients with Down Syndrome—Treatment and Outcome Results from an Institution in Argentina

Children with Down syndrome (DS) are at an increased risk of developing clonal myeloproliferative disorders. The balance between treatment intensity and treatment-related toxicity has not yet been defined. We analyzed this population to identify risk factors and optimal treatment. This single-center...

Full description

Bibliographic Details
Main Authors: Carla L. Pennella, Tamara Muñoz Cassina, Jorge G. Rossi, Edgardo M. Baialardo, Patricia Rubio, María A. Deu, Luisina Peruzzo, Myriam R. Guitter, Cristian G. Sanchez de La Rosa, Elizabeth M. Alfaro, María S. Felice
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Cancers
Subjects:
Down Syndrome
acute myeloid leukemia
transient abnormal myelopoiesis
megakaryoblastic leukemia
chemotherapy
outcome research
Online Access:https://www.mdpi.com/2072-6694/14/13/3286

Internet

https://www.mdpi.com/2072-6694/14/13/3286

Similar Items